Belgium· BE-AMP-SAM173101-00

Meronem IV 1 g

A meropenem product containing meropenem trihydrate, registered in Belgium by Pfizer. The same ATC class is registered in 18 of our 19 countries.

ATC J01DH02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about meropenem trihydrateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Meropenem is registered in 18 of 19 countries.

Countries holding a registration under ATC J01DH02 (meropenem), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search meropenem products by name

Meropenem · ATC J01DH02

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of meropenem costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Meropenem · price per daily dose (3 g)

USD · FX 28 Sept 2026

CH Switzerland$99.79

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Meropenem Trihydrate
Manufacturer: Pfizer
Country: Belgium (BE)
ATC code: J01DH02
ATC class: Meropenem
Defined daily dose: 3 g, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 3

1 priced

be_apb
3727443
EUR 90.17
be_apb
1171289
be_apb
0745414

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for meropenem.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check meropenem against other medicines How interaction checks work

Meropenem · interactions on record

25 records

4 severe
20 moderate

Most severe, free to view

BupropionN06AX12severe
BupropionN07BA02severe
IohexolV08AB02severe
IopamidolV08AB04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Meropenem in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All meropenem products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Merinfec, Meropenem Aptapharma
Bulgaria · Meropenem Kabi, Meropenem-Tchaikapharma
Cyprus · Archifar, Meropenem Aptapharma
Czechia · Archifar, Meronem
Germany · Meropenem, Meropenem Acs Dobfar
Denmark · Merocarb, Meropenem "thrive"
Estonia · Agenor, Meropenem Bausch Health
Spain · Archifar, Meropenem Aurovit
Finland · Merocarb, Meropenem Aptapharma
France · Meronem, Meropenem Acs Dobfar
United Kingdom (Northern Ireland) · Meronem Iv, Meropenem
Greece · Carbenem, Homepen
Croatia · Archifar, Meropenem Aptapharma
Hungary · Meropenem Aptapharma, Meropenem Bradex
Ireland · Meronem I.V., Meropenem
Iceland · Merinfec, Merocarb
Italy · Luxomer, Meropenem Acs Dobfar
Lithuania · Agenorem, Meropenem Kabi
Luxembourg · Meronem Iv, Meropenem Bradex
Latvia · Archifar, Meropenem Kabi
Malta · Archifar, Mepenex
Netherlands · Meropenem Aptapharma, Meropenem Bradex
Norway · Merocarb, Meropenem Aptapharma
Poland · Meronem, Meropenem Aptapharma
Portugal · Meropenem Atral, Meropenem Aurovitas
Romania · Archifar, Loditer
Sweden · Merocarb, Meronem
Slovenia · Archifar, Meropenem Actavis
Slovakia · Archifar, Merocarb

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/214b22b0-9503-45ff-b73f-76b11dcadf48
GET /v1/drugs/214b22b0-9503-45ff-b73f-76b11dcadf48?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection/infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Meronem IV 1 g",
  "name_fr": "Meronem IV 1 g",
  "name_nl": "Meronem IV 1 g",
  "amp_code": "SAM173101-00",
  "strengths": [
    "1140.0000",
    "1000.4000",
    "208.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Meropenem Trihydrate",
    "Meropenem",
    "Sodium Carbonate Anhydrous"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Meropenem",
  "authorisation_numbers": [
    "BE173101"
  ]
}

API reference MCP server Plans

See everything about meropenem.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console